Cryopreservation moderates the thrombogenicity of arterial allografts during storage.
<h4>Introduction</h4>Management of vascular infections represents a major challenge in vascular surgery. The use of cryopreserved vascular allografts could be a feasible therapeutic option, but the optimal conditions for their production and use are not precisely defined.<h4>Aims&l...
Guardado en:
Autores principales: | László Hidi, Erzsébet Komorowicz, Gergely Imre Kovács, Zoltán Szeberin, Dávid Garbaisz, Natalia Nikolova, Kiril Tenekedjiev, László Szabó, Krasimir Kolev, Péter Sótonyi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9353e369935f4b2c933d3d62da22a259 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanomedicine for the reduction of the thrombogenicity of stent coatings
por: Varvara C Karagkiozaki, et al.
Publicado: (2010) -
Surface modification of decellularized bovine carotid arteries with human vascular cells significantly reduces their thrombogenicity
por: Eriselda Keshi, et al.
Publicado: (2021) -
Decellularized versus cryopreserved pulmonary allografts for right ventricular outflow tract reconstruction during the Ross procedure: a meta-analysis of short- and long-term outcomes
por: Adham Ahmed, et al.
Publicado: (2021) -
Decreasing temperature enhances the formation of sixfold hydrogen bonded rings in water-rich water-methanol mixtures
por: Imre Bakó, et al.
Publicado: (2017) -
Cardiovascular risk factors are associated with augmented thrombogenicity in healthy individuals: analysis using the Total Thrombus-formation Analysis System
por: Yuu Oda, et al.
Publicado: (2021)